- Home
- GLPG vs DSGR Comparison
GLPG vs DSGR Comparison
Compare GLPG & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- DSGR
- Stock Information
- Founded
- GLPG 1999
- DSGR 1952
- Country
- GLPG Belgium
- DSGR United States
- Employees
- GLPG N/A
- DSGR N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- DSGR Industrial Machinery/Components
- Sector
- GLPG Health Care
- DSGR Industrials
- Exchange
- GLPG Nasdaq
- DSGR Nasdaq
- Market Cap
- GLPG 1.8B
- DSGR 1.4B
- IPO Year
- GLPG 2005
- DSGR N/A
- Fundamental
- Price
- GLPG $24.77
- DSGR $28.15
- Analyst Decision
- GLPG Sell
- DSGR Buy
- Analyst Count
- GLPG 5
- DSGR 2
- Target Price
- GLPG $26.75
- DSGR $43.00
- AVG Volume (30 Days)
- GLPG 159.3K
- DSGR 55.3K
- Earning Date
- GLPG 04-23-2025
- DSGR 05-01-2025
- Dividend Yield
- GLPG N/A
- DSGR N/A
- EPS Growth
- GLPG N/A
- DSGR N/A
- EPS
- GLPG 1.16
- DSGR N/A
- Revenue
- GLPG $285,380,474.00
- DSGR $1,804,104,000.00
- Revenue This Year
- GLPG $0.08
- DSGR $14.79
- Revenue Next Year
- GLPG $0.23
- DSGR $4.44
- P/E Ratio
- GLPG $21.58
- DSGR N/A
- Revenue Growth
- GLPG 14.99
- DSGR 14.88
- 52 Week Low
- GLPG $22.36
- DSGR $27.30
- 52 Week High
- GLPG $32.17
- DSGR $41.47
- Technical
- Relative Strength Index (RSI)
- GLPG 38.92
- DSGR 41.14
- Support Level
- GLPG $24.48
- DSGR $27.30
- Resistance Level
- GLPG $25.72
- DSGR $28.90
- Average True Range (ATR)
- GLPG 0.51
- DSGR 0.89
- MACD
- GLPG -0.15
- DSGR -0.04
- Stochastic Oscillator
- GLPG 14.15
- DSGR 24.71
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.